Author

S. Rahmy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

S. Murphy· 2 shared X. Lu· 2 shared D. Gan· 1 shared E. Albano· 1 shared J. H. Schofield· 1 shared J. Li· 1 shared J. Longo· 1 shared L. Duong· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Murphy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides

J. H. Schofield, J. Longo, R. Sheldon, E. Albano, M. A. Hawk, S. Murphy, L. Duong, S. Rahmy, X. Lu, R. G. Jones, Z. T. Schafer

This study shows that Acod1 in cancer cells promotes immune evasion by releasing inhibitory peptides, not ITA, and that reducing Acod1 can make tumors responsive to PD-1 therapy.

bioRxiv · Sep 14, 2023Cancer Biology

Overcome Prostate Cancer Resistance to Immune Checkpoint Therapy with Ketogenic Diet-Induced Epigenetic Reprogramming

S. Murphy, S. Rahmy, D. Gan, Y. Zhu, M. Manyak, J. Li, X. Lu, X. Lu

This study shows that combining ketogenic diet and HDAC inhibitors with ICB therapy enhances anti-tumor effects in prostate cancer by modulating epigenetic and immune mechanisms.

bioRxiv · Aug 7, 2023 · PreprintCancer Biology